HELIUS MINERALS LTD (HHH.CA) Fundamental Analysis & Valuation

TSX-V:HHH • CA42329R1064

Current stock price

4.8 CAD
+0.04 (+0.84%)
Last:

This HHH.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. HHH.CA Profitability Analysis

1.1 Basic Checks

  • HHH had negative earnings in the past year.
  • HHH had a negative operating cash flow in the past year.
  • In the past 5 years HHH always reported negative net income.
  • In the past 5 years HHH always reported negative operating cash flow.
HHH.CA Yearly Net Income VS EBIT VS OCF VS FCFHHH.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -500K -1M -1.5M

1.2 Ratios

Industry RankSector Rank
ROA -82.74%
ROE -143.36%
ROIC N/A
ROA(3y)-35.13%
ROA(5y)-32.93%
ROE(3y)-84.27%
ROE(5y)-73.36%
ROIC(3y)N/A
ROIC(5y)N/A
HHH.CA Yearly ROA, ROE, ROICHHH.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for HHH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HHH.CA Yearly Profit, Operating, Gross MarginsHHH.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. HHH.CA Health Analysis

2.1 Basic Checks

  • HHH has about the same amout of shares outstanding than it did 1 year ago.
  • HHH has more shares outstanding than it did 5 years ago.
  • HHH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HHH.CA Yearly Shares OutstandingHHH.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
HHH.CA Yearly Total Debt VS Total AssetsHHH.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M

2.2 Solvency

  • HHH has an Altman-Z score of 95.75. This indicates that HHH is financially healthy and has little risk of bankruptcy at the moment.
  • There is no outstanding debt for HHH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 95.75
ROIC/WACCN/A
WACCN/A
HHH.CA Yearly LT Debt VS Equity VS FCFHHH.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500K -500K -1M

2.3 Liquidity

  • A Current Ratio of 1.22 indicates that HHH should not have too much problems paying its short term obligations.
  • A Quick Ratio of 1.22 indicates that HHH should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
HHH.CA Yearly Current Assets VS Current LiabilitesHHH.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. HHH.CA Growth Analysis

3.1 Past

  • HHH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -241.27%.
EPS 1Y (TTM)-241.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-388.89%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. HHH.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • HHH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HHH.CA Price Earnings VS Forward Price EarningsHHH.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HHH.CA Per share dataHHH.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 -0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HHH.CA Dividend Analysis

5.1 Amount

  • HHH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HHH.CA Fundamentals: All Metrics, Ratios and Statistics

HELIUS MINERALS LTD

TSX-V:HHH (3/27/2026, 7:00:00 PM)

4.8

+0.04 (+0.84%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners29.92%
Ins Owner ChangeN/A
Market Cap195.65M
Revenue(TTM)N/A
Net Income(TTM)-1.58M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 128.03
P/tB 128.03
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.04
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -82.74%
ROE -143.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-35.13%
ROA(5y)-32.93%
ROE(3y)-84.27%
ROE(5y)-73.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z 95.75
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-241.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-388.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-257.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-24.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-35.54%
OCF growth 3YN/A
OCF growth 5YN/A

HELIUS MINERALS LTD / HHH.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for HELIUS MINERALS LTD?

ChartMill assigns a fundamental rating of 2 / 10 to HHH.CA.


What is the valuation status of HELIUS MINERALS LTD (HHH.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to HELIUS MINERALS LTD (HHH.CA). This can be considered as Overvalued.


Can you provide the profitability details for HELIUS MINERALS LTD?

HELIUS MINERALS LTD (HHH.CA) has a profitability rating of 0 / 10.


How financially healthy is HELIUS MINERALS LTD?

The financial health rating of HELIUS MINERALS LTD (HHH.CA) is 6 / 10.